Agilent Technologies saw its stock decline roughly 7% on Thursday after releasing first-quarter results that came in just below analyst expectations. The life sciences and diagnostics company reported diluted earnings per share of $1.36 for the quarter, compared with the analyst consensus of $1.37. Revenue for the period was $1.8 billion, short of the $1.81 billion estimate.
Market reaction to the report reflected the narrow misses on both EPS and top-line figures following the quarter that was disclosed on Wednesday. The share price movement on Thursday followed the publication of those results.
Forward guidance and consensus comparisons
Agilent provided guidance for the second quarter of fiscal 2026 that includes an EPS range of $1.39 to $1.42, which brackets the analyst consensus point estimate of $1.39. For revenue, the company projected $1.79 billion to $1.82 billion for Q2, a range that sits above the consensus estimate of $1.767 billion.
For the full fiscal year 2026, Agilent issued an EPS forecast of $5.90 to $6.04, compared with the consensus EPS of $5.93. Full-year revenue guidance was stated as $7.3 billion to $7.5 billion, relative to a consensus figure of $7.355 billion.
What the numbers show
- The reported Q1 EPS of $1.36 missed the $1.37 consensus by a small margin.
- Q1 revenue of $1.8 billion likewise fell short of the $1.81 billion consensus.
- Q2 revenue guidance is presented as a range above consensus, while Q2 EPS guidance overlaps the consensus estimate.
- Full-year 2026 EPS and revenue guidance are provided as ranges that closely bracket consensus estimates.
Market and sector context
The company is identified as operating in life sciences and diagnostics. The report and guidance have immediate implications for Agilent shareholders and for market participants tracking companies in the life sciences and diagnostics sector. Beyond the immediate price reaction, the guidance ranges will be used by analysts and investors to reassess near-term expectations.
Notes on information
All figures and comparisons above are taken from Agilent Technologies' disclosed quarterly results and the consensus estimates referenced alongside that disclosure. The article does not add additional data or interpretative claims beyond those provided in the company's report and the consensus points cited.